LAWSUITS NEWS & LEGAL INFORMATION
Proton Pump Inhibitor Gastric Cancer Legal News Articles & Interviews
December 31, 2020. By Jane Mundy.
Read [ Proton Pump Inhibitors – More Harm than Good, especially in COVID-19 Patients ]
Santa Clara, CA Over the past several years, Proton Pump Inhibitors (PPI) have been linked to serious health complications. And more recent studies indicate that these acid reflux drugs do more harm than good. One such study opines that PPI exposure increases mortality in COVID-19 patients. Other studies suggest PPIs can damage major organs and regular use of PPI is linked to a higher risk of being diagnosed with type 2 diabetes and serious skin reactions such as life-threatening Stevens-Johnson Syndrome. And there is more…
November 28, 2020. By Jane Mundy.
Read [ “Acid Reflux Drugs Caused my Type 2 Diabetes” ]
Phoenix, AZ Ten years ago Gary Phillips was diagnosed with type 2 diabetes. He had taken proton pump inhibitor (PPI) medications for acid reflux issues at least once a day for about 13 years but only knew that the medications were linked to diabetes when he read about PPI lawsuits. Unfortunately the meds worked— so he kept taking them. Now he takes insulin shots.
October 25, 2020. By Jane Mundy.
Read [ Regular Acid-reflux Drug Use Linked to Higher Risk of type 2 Diabetes ]
Santa Clara, CA During this Pandemic there is also an epidemic that has been growing for decades and it is just as dangerous, perhaps even more so, than COVID 19. And drugs known as proton pump inhibitors or PPIs are feeding this epidemic: type 2 diabetes.
Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow
May 31, 2018. By Jane Mundy.
Santa Clara, CA: A link between proton pump inhibitors (PPIs) and high risk of gastric cancer isn’t new, but the results of a new study conflicts with the FDA’s mandated PPI study.Read [ Study Further Links Proton Pump Inhibitors to Gastric Cancer and Conflicts with FDA study, Lawsuits to Follow ]
March 4, 2018. By Gordon Gibb.
Newark, NJ: Heartburn, more correctly known as acid reflux, continues to be a common complaint affecting a vast cross section of the American population. Relief is often in the form of medication - and, specifically proton pump inhibitors such as Nexium, a product of AstraZeneca. Plaintiff Shirlene Bonner began regular use of Nexium to relieve heartburn from 2003 until 2015, until a diagnosis of chronic kidney disease (CKD) found her searching for answers as to what may have triggered her CKD. Bonner alleges in her PPI lawsuit that Nexium, a proton pump inhibitor, is the root cause.Read [ Georgia Plaintiff Alleges Use of Nexium Caused Chronic Kidney Disease ]
February 5, 2018. By Anne Wallace.
Washington, DC: As many as 80 percent of expectant mothers suffer from heartburn or acid indigestion during pregnancy. Until recently proton pump inhibitors (PPIs), such as Nexium, Prilosec and Prevacid, were thought to be both effective for mom and safe for baby.Read [ Childhood Asthma Risk Linked to Mother’s PPI Use during Pregnancy ]